casirivimab/imdevimab (Q99328880)
Jump to navigation
Jump to search
experimental anti-COVID-19 drug developed by Regeneron
- REGN-COV2
- REGN-COV
- Ronapreve
- REGN10933/REGN10987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | casirivimab/imdevimab |
experimental anti-COVID-19 drug developed by Regeneron |
|
Statements
2020
0 references
REGN-COV2 (English)
0 references
Casirivimab/imdevimab
0 references
Identifiers
Sitelinks
Wikipedia(18 entries)
- arwiki كاسيريفيماب/إيميفيماب
- cawiki Casirivimab/imdevimab
- cswiki Kasirivimab/imdevimab
- dewiki Casirivimab/Imdevimab
- elwiki Κασιριβιμάμπη/ιμντεβιμάμπη
- enwiki Casirivimab/imdevimab
- eswiki Casirivimab/imdevimab
- frwiki REGN-COV2
- jawiki カシリビマブ・イムデビマブ
- kowiki REGN-COV2
- nowiki REGN-COV2
- orwiki କାସିରିଭିମାବ/ଇମଡେଭିମାବ
- plwiki Kasiriwimab/imdewimab
- ptwiki REGN-COV2
- ruwiki Казиривимаб/имдевимаб
- slwiki Kasirivimab/imdevimab
- thwiki คาซิริวิแมบ/อิมดีวิแมบ
- ukwiki Касиривімаб/імдевімаб
Wikibooks(0 entries)
Wikinews(0 entries)
Wikiquote(0 entries)
Wikisource(0 entries)
Wikiversity(0 entries)
Wikivoyage(0 entries)
Wiktionary(0 entries)
Multilingual sites(1 entry)
- commonswiki Category:Casirivimab/imdevimab